A Placebo-Controlled Study of Trazodone in Bulimia Nervosa

Harrison Graham Pope · Paul E. Keck · Susan L. McElroy · James I. Hudson

100 citations0/0 files storedJournal of Clinical Psychopharmacology

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Eating Disorders and Behaviors Nutrition, Health and Food Behavior Pharmacology and Obesity Treatment

Abstract

Forty-two women who met the new narrower criteria for bulimia nervosa of DSM-III-R completed a placebo-controlled double-blind study with trazodone. The drug proved significantly superior to placebo, both in measures of frequency of binge eating and vomiting and in the patients' subjective assessments of improvement. Trazodone produced few adverse effects.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 100 citations exist upstream.

Cited by

2018Efficacy of psychotherapies and pharmacotherapies for Bulimia nervosa 2008What potential role is there for medication treatment in anorexia nervosa?2001Antidepressants versus psychological treatments and their combination for bulimia nervosa 1993Practice guideline for eating disorders. American Psychiatric Association 2018Treatments for bulimia nervosa: a network meta-analysis 1993A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa 2001The Relative Efficacy of Fluoxetine and Manual-Based Self-Help in the Treatment of Outpatients With Bulimia Nervosa 2019Pharmacologic Treatment of Eating Disorders

Imported from OpenAlex (CC0) — nothing here is generated.